论文部分内容阅读
川崎病是全身性血管炎的最常见病因，同时又是小儿后天性心脏病的最主要病因，未经合理治疗的川崎病患儿，其冠状动脉病变（冠状动脉瘤、冠状动脉扩张及继发性节段性狭窄）的发生率高达ZO％～25％，约2％患儿死于心肌梗死或动脉瘤破裂。本文观察大剂量丙种球蛋白治疗川崎病的临
Kawasaki disease is the most common cause of systemic vasculitis, but also the most important cause of acquired heart disease in children with unreasonable treatment of children with Kawasaki disease, its coronary lesions (coronary aneurysm, coronary artery dilatation and secondary Sexual segmental stenosis) incidence of up to 25% of ZO, about 2% of children died of myocardial infarction or aneurysm rupture. This article observed the high dose of gamma globulin treatment of Kawasaki disease